Download App

Log in to access Online Inquiry
Company Overview More
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company’s products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
CEO: Caforio M.D., Giovanni
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > BMY Bristol-Myers Squibb > Detailed Quotes

BMY Bristol-Myers Squibb

76.9100.0000.00%
Close 05/17 00:00 ET
77.160+0.25+0.33%
Pre Mkt Price 05/17 09:27 ET
High
0.000
Open
0.000
Turnover
0
Low
0.000
Pre Close
76.910
Volume
0
Market Cap
163.75B
P/E(TTM)
27.27
52wk High
78.170
Shares
2.13B
P/E(Static)
24.65
52wk Low
52.371
Float Cap
162.85B
Bid/Ask %
88.57%
Historical High
78.170
Shs Float
2.12B
Volume Ratio
0.00
Historical Low
9.152
Dividend TTM
2.06
Div Yield TTM
--
P/B
5.19
Dividend LFY
2.68%
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.000
Lot Size
1
Float Cap
162.85B
Bid/Ask %
88.57%
Historical High
78.170
Shs Float
2.12B
Volume Ratio
0.00
Historical Low
9.152
Dividend TTM
2.06
P/B
5.19
Dividend LFY
2.68%
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.000
Lot Size
1
Price Forecast

No Data

News

Comment